首页> 美国卫生研究院文献>The Journal of Experimental Medicine >Differential effects of chlorpromazine on the in vitro generation and effector function of cytotoxic lymphocytes
【2h】

Differential effects of chlorpromazine on the in vitro generation and effector function of cytotoxic lymphocytes

机译:氯丙嗪对细胞毒性淋巴细胞体外产生及效应功能的差异作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Allograft rejection represents a cytotoxic response mediated to a large degree by thymus-derived T lymphocytes (1). The study of such cell-mediated cytotoxic phenomena has been greatly facilitated by the discovery first noted by Hayry and Defendi (2) and Wunderlich and Cany (3), that a natural consequence of allogeneic stimulation in an unidirectional mixed lymphocyte culture (MLC) was the appearance of cytotoxic lymphocytes specific for antigens present on the stimulator cells. Subsequent studies have shown that such in vitro generation of cytotoxic lymphocytes was dependent on the proliferative response in an MLC (4), was genetically determined (5), and possibly required the interaction of several subpopulations of T cells (6). We now report that the surface active agent chlorpromazine: (a) inhibits allogeneic stimulation of the proliferative response in an MLC; (b) inhibits the MLC generation of cytotoxic lymphocytes, (c) has no effect on the recognition, binding, or lysis of target cells by already sensitized lymphocytes; and (d) blocks a postproliferative membrane-mediated event, independent of proliferation, and necessary for the MLC generation of cytotoxic lymphocytes.
机译:同种异体移植排斥反应是由胸腺来源的T淋巴细胞在很大程度上介导的细胞毒性反应(1)。 Hayry和Defendi(2)和Wunderlich和Cany(3)首先指出的发现大大促进了这种细胞介导的细胞毒性现象的研究,即单向混合淋巴细胞培养(MLC)中的同种异体刺激的自然结果是对刺激细胞上存在的抗原具有特异性的细胞毒性淋巴细胞的出现。随后的研究表明,这种细胞毒性淋巴细胞的体外生成取决于MLC中的增殖反应(4),是通过遗传确定的(5),并且可能需要多个T细胞亚群的相互作用(6)。现在我们报告表面活性剂氯丙嗪:(a)抑制MLC中增殖反应的同种异体刺激; (b)抑制细胞毒性淋巴细胞的MLC生成,(c)对已经敏化的淋巴细胞对靶细胞的识别,结合或裂解没有影响; (d)阻断增殖后膜介导的事件,与增殖无关,并且对于细胞毒性淋巴细胞的MLC生成是必需的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号